Eventiko Stock Price, News & Analysis
Company Description
Eventiko (OTC Link: EVTK) is a publicly traded personal services company in the Consumer Cyclical sector. The company has a market capitalization of $12.6M.
EVTK stock has declined 36.8% over the past year. Shares last traded at $3.00.
On a trailing twelve-month basis, Eventiko reported revenue of $0 with net income of -$10K and diluted earnings per share of $0.00.
This page provides a comprehensive overview of EVTK stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eventiko (EVTK) stock last traded at $3.00. Over the past 12 months, the stock has lost 36.8%. At a market capitalization of $12.6M, EVTK is classified as a micro-cap stock with approximately 4.2M shares outstanding.
EVTK Rankings
Latest News
SEC Filings
Eventiko has filed 3 recent SEC filings, including 2 Form 10-Q, 1 Form NT 10-Q. The most recent filing was submitted on March 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EVTK SEC filings →
Financial Highlights
operating income reached -$24K, and net income was -$10K. Diluted earnings per share stood at $0.00. The company generated -$24K in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Eventiko (EVTK) currently stands at 25 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 91.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Eventiko (EVTK) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
EVTK Company Profile & Sector Positioning
Eventiko (EVTK) operates in the Personal Services industry within the broader Consumer Cyclical sector and is listed on the OTC Link.